Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells

James L. Weaver, P. Scott Pine, Adorjan Aszalos, Patricia V Schoenlein, Stephen J. Currier, Raji Padmanabhan, Michael M. Gottesman

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

The multidrug-resistant gene (MDR1) encodes an energy-dependent drug efflux pump (P-glycoprotein) for many anti-cancer drugs. We have studied the intracellular distribution of rhodamine 123 (R123), daunorubicin (DN), and doxorubicin (DOX) in cells expressing a human MDR1 gene. The distribution of these fluorescent drugs was measured by laser scanning microscopy and confocal microscopy. We devised a new method for analysis of fluorescence line scan data to determine the intracellular distribution of fluorescent probes. This method and confocal microscopy showed that R123, DN, and DOX are localized to both plasma membrane and intracellular compartments in multidrug-resistant cells. When the cells are treated with verapamil, an inhibitor of the multidrug transporter, the amount of DOX, DN, and R123 associated with the cell rises. After inhibition, the relative distribution of DOX and DN between the cell surface and intracellular structures does not change dramatically. However, R123 tends to relocalize to intracellular sites from predominantly plasma membrane sites, indicating that this dye behaves differently than the anti-cancer drugs. These results show the subcellular distributions of R123, DN, and DOX in plasma membrane, cytoplasm, and intracellular membrane systems, but do not allow definitive distinctions among existing models of how P-glycoprotein affects the distribution of drugs.

Original languageEnglish (US)
Pages (from-to)323-329
Number of pages7
JournalExperimental Cell Research
Volume196
Issue number2
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Rhodamine 123
Daunorubicin
Confocal Microscopy
Doxorubicin
Pharmaceutical Preparations
Cell Membrane
P-Glycoprotein
Intracellular Membranes
Verapamil
Fluorescent Dyes
Genes
Neoplasms
Cytoplasm
Coloring Agents
Fluorescence

ASJC Scopus subject areas

  • Cell Biology

Cite this

Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells. / Weaver, James L.; Pine, P. Scott; Aszalos, Adorjan; Schoenlein, Patricia V; Currier, Stephen J.; Padmanabhan, Raji; Gottesman, Michael M.

In: Experimental Cell Research, Vol. 196, No. 2, 01.01.1991, p. 323-329.

Research output: Contribution to journalArticle

Weaver, James L. ; Pine, P. Scott ; Aszalos, Adorjan ; Schoenlein, Patricia V ; Currier, Stephen J. ; Padmanabhan, Raji ; Gottesman, Michael M. / Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells. In: Experimental Cell Research. 1991 ; Vol. 196, No. 2. pp. 323-329.
@article{871033507b804859899ec5badb526eb6,
title = "Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells",
abstract = "The multidrug-resistant gene (MDR1) encodes an energy-dependent drug efflux pump (P-glycoprotein) for many anti-cancer drugs. We have studied the intracellular distribution of rhodamine 123 (R123), daunorubicin (DN), and doxorubicin (DOX) in cells expressing a human MDR1 gene. The distribution of these fluorescent drugs was measured by laser scanning microscopy and confocal microscopy. We devised a new method for analysis of fluorescence line scan data to determine the intracellular distribution of fluorescent probes. This method and confocal microscopy showed that R123, DN, and DOX are localized to both plasma membrane and intracellular compartments in multidrug-resistant cells. When the cells are treated with verapamil, an inhibitor of the multidrug transporter, the amount of DOX, DN, and R123 associated with the cell rises. After inhibition, the relative distribution of DOX and DN between the cell surface and intracellular structures does not change dramatically. However, R123 tends to relocalize to intracellular sites from predominantly plasma membrane sites, indicating that this dye behaves differently than the anti-cancer drugs. These results show the subcellular distributions of R123, DN, and DOX in plasma membrane, cytoplasm, and intracellular membrane systems, but do not allow definitive distinctions among existing models of how P-glycoprotein affects the distribution of drugs.",
author = "Weaver, {James L.} and Pine, {P. Scott} and Adorjan Aszalos and Schoenlein, {Patricia V} and Currier, {Stephen J.} and Raji Padmanabhan and Gottesman, {Michael M.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0014-4827(91)90267-X",
language = "English (US)",
volume = "196",
pages = "323--329",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells

AU - Weaver, James L.

AU - Pine, P. Scott

AU - Aszalos, Adorjan

AU - Schoenlein, Patricia V

AU - Currier, Stephen J.

AU - Padmanabhan, Raji

AU - Gottesman, Michael M.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The multidrug-resistant gene (MDR1) encodes an energy-dependent drug efflux pump (P-glycoprotein) for many anti-cancer drugs. We have studied the intracellular distribution of rhodamine 123 (R123), daunorubicin (DN), and doxorubicin (DOX) in cells expressing a human MDR1 gene. The distribution of these fluorescent drugs was measured by laser scanning microscopy and confocal microscopy. We devised a new method for analysis of fluorescence line scan data to determine the intracellular distribution of fluorescent probes. This method and confocal microscopy showed that R123, DN, and DOX are localized to both plasma membrane and intracellular compartments in multidrug-resistant cells. When the cells are treated with verapamil, an inhibitor of the multidrug transporter, the amount of DOX, DN, and R123 associated with the cell rises. After inhibition, the relative distribution of DOX and DN between the cell surface and intracellular structures does not change dramatically. However, R123 tends to relocalize to intracellular sites from predominantly plasma membrane sites, indicating that this dye behaves differently than the anti-cancer drugs. These results show the subcellular distributions of R123, DN, and DOX in plasma membrane, cytoplasm, and intracellular membrane systems, but do not allow definitive distinctions among existing models of how P-glycoprotein affects the distribution of drugs.

AB - The multidrug-resistant gene (MDR1) encodes an energy-dependent drug efflux pump (P-glycoprotein) for many anti-cancer drugs. We have studied the intracellular distribution of rhodamine 123 (R123), daunorubicin (DN), and doxorubicin (DOX) in cells expressing a human MDR1 gene. The distribution of these fluorescent drugs was measured by laser scanning microscopy and confocal microscopy. We devised a new method for analysis of fluorescence line scan data to determine the intracellular distribution of fluorescent probes. This method and confocal microscopy showed that R123, DN, and DOX are localized to both plasma membrane and intracellular compartments in multidrug-resistant cells. When the cells are treated with verapamil, an inhibitor of the multidrug transporter, the amount of DOX, DN, and R123 associated with the cell rises. After inhibition, the relative distribution of DOX and DN between the cell surface and intracellular structures does not change dramatically. However, R123 tends to relocalize to intracellular sites from predominantly plasma membrane sites, indicating that this dye behaves differently than the anti-cancer drugs. These results show the subcellular distributions of R123, DN, and DOX in plasma membrane, cytoplasm, and intracellular membrane systems, but do not allow definitive distinctions among existing models of how P-glycoprotein affects the distribution of drugs.

UR - http://www.scopus.com/inward/record.url?scp=0026051623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026051623&partnerID=8YFLogxK

U2 - 10.1016/0014-4827(91)90267-X

DO - 10.1016/0014-4827(91)90267-X

M3 - Article

C2 - 1680064

AN - SCOPUS:0026051623

VL - 196

SP - 323

EP - 329

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -